Kimberly Anne Bertrand, ScD
Associate Professor, Medicine
Biography
Dr. Bertrand’s research focuses primarily on the epidemiology of cancer, with an emphasis on understanding racial disparities in incidence and outcomes. She is currently Multiple Principal Investigator of the Black Women’s Health Study (BWHS), a prospective cohort study of over 59,000 self-identified Black women begun in 1995. Dr. Bertrand is actively involved in several epidemiologic studies to evaluate risk factors for high mammographic density, a strong independent predictor of breast cancer, and the role mammographic density and other risk factors may play in breast tumor aggressiveness in this and other populations. In addition, she leads research to identify factors that explain racial disparities in multiple myeloma.
Other Positions
- Associate Professor, Slone Epidemiology Center, Boston University Chobanian & Avedisian School of Medicine
- Center Faculty Member, Slone Epidemiology Center, Boston University Chobanian & Avedisian School of Medicine
- Member, BU-BMC Cancer Center, Boston University
- Epidemiologist, Slone Epidemiology Center, Boston University Chobanian & Avedisian School of Medicine
- Member, Genome Science Institute, Boston University
Education
- Harvard School of Public Health, ScD
- Boston University School of Public Health, MPH
- Brown University, BS
Publications
- Published on 8/2/2024
Bigham Z, Holder EX, Rodday AM, Breeze J, Nelson KP, Palmer JR, Freund KM, Bertrand KA. Lifecourse growth and development determinants of mammographic density in Black women. Cancer Epidemiol Biomarkers Prev. 2024 Aug 02. PMID: 39093038.
Read at: PubMed - Published on 7/18/2024
Titus L, Hatch EE, Bertrand KA, Palmer JR, Strohsnitter WC, Huo D, Curry M, Hyer M, Aagaard K, Gierach GL, Troisi R. Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study. Cancers (Basel). 2024 Jul 18; 16(14). PMID: 39061214.
Read at: PubMed - Published on 6/3/2024
Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gallagher G, Gierach GL, Goodman MT, Jordan SJ, La Vecchia C, Lacey JV, Levi F, Liao LM, Lipworth L, Lu L, Matias-Guiu X, Moysich KB, Mutter GL, Na R, Naduparambil J, Negri E, O'Connell K, O'Mara TA, Onieva Hernández I, Palmer JR, Parazzini F, Patel AV, Penney KL, Prizment AE, Ricceri F, Risch HA, Sacerdote C, Sandin S, Stolzenberg-Solomon RZ, van den Brandt PA, Webb PM, Wentzensen N, Wijayabahu AT, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Du M, Setiawan VW. Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev. 2024 Jun 03; 33(6):788-795. PMID: 38530242.
Read at: PubMed - Published on 2/29/2024
Troisi R, Bertrand K, Hatch EE, Strohsnitter WC, Aagaard K, Robboy SJ, Gierach G, Titus L. An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract. Obstet Gynecol. 2024 Apr 01; 143(4):603-606. PMID: 38422500.
Read at: PubMed - Published on 2/19/2024
Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545. PMID: 38377945.
Read at: PubMed - Published on 1/12/2024
Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the Black Women's Health Study. Br J Cancer. 2024 Mar; 130(5):830-835. PMID: 38212484.
Read at: PubMed - Published on 1/10/2024
Wolfson EA, Schonberg MA, Eliassen AH, Bertrand KA, Shvetsov YB, Rosner BA, Palmer JR, LaCroix AZ, Chlebowski RT, Nelson RA, Ngo LH. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older. J Natl Cancer Inst. 2024 Jan 10; 116(1):81-96. PMID: 37676833.
Read at: PubMed - Published on 1/9/2024
Bertrand KA, Szalat R. Deciphering racial disparities in multiple myeloma outcomes. Blood Adv. 2024 Jan 09; 8(1):234-235. PMID: 38194241.
Read at: PubMed - Published on 1/2/2024
Zirpoli GR, Pfeiffer RM, Bertrand KA, Huo D, Lunetta KL, Palmer JR. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Res. 2024 Jan 02; 26(1):2. PMID: 38167144.
Read at: PubMed - Published on 12/11/2023
Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, Håkansson N, Hankinson SE, Houlston RS, Joshu CE, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Lynch BM, May AM, Mellemkjær L, Milne RL, Palmer JR, Ricceri F, Rohan TE, Ruddy KJ, Sánchez MJ, Shu XO, Smith-Byrne K, Steindorf K, Sund M, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zheng W, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 2024 Mar 10; 42(8):927-939. PMID: 38079601.
Read at: PubMed
View 141 more publications: View full profile at BUMC